Novo Nordisk Background

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

The Wall Street Journal on MSN · 3h

FDA Declares Shortage of Novo Nordisk’s Wegovy, Ozempic Over

The FDA announcement confirms that the U.S. supply of both prescription-only drugs now meets or exceeds the current and projected demand in the country, the Danish pharmaceutical company said.

Business Insider · 2h

Shortage of Novo Nordisk’s (NVO) Weight Loss Drugs Is Resolved, Says FDA

The shortage of Novo Nordisk’s (NVO) blockbuster weight loss drugs has been resolved, according to the U.S. Food and Drug Administration

3hon MSN

Why Novo Nordisk Stock Popped on Friday

Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...

16d

Novo Nordisk Has Probably Declined Enough

Novo Nordisk's recent decline suggests it may be a Buy again, with strong growth prospects in diabetes and obesity treatments. Click to read why NVO stock is a Buy.

pharmaphorum3d

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Trending now